|
Napp Pharmaceuticals is part of a worldwide association of independent
pharmaceutical companies that have been developing vital new drugs for more
than half a century.
Napp pioneered the creation of prolonged release drugs, particularly for the
relief of severe pain. Its development of controlled-release morphine sulphate
tablets (MST® Continus® tablets) was a world first, and it now produces 18
analgesics in 52 different formulations. Napp also produces a number of other
medicines for the treatment of cardiovascular disease, respiratory disease and
gastrointestinal problems.
The company moved to the prestigious Cambridge Science Park in the early
1980s, opening its striking UK headquarters building in 1983.
The success of its research and sales operations has seen the number of
employees grow to more than 800, and Napp's facilities have expanded into
three other buildings on the Science Park.
Napp's sales have grown significantly and it is now rated 18th by size of
prescription-only medicine sales among 230 companies in the UK pharmaceutical
industry.
|  |
 |